Impact of Intestinal Bacteria on Levodopa Pharmacokinetics in LCIG Therapy.
Yuki YamanishiMohammed Emamussalehin ChoudhuryAkira YoshidaYuko HosokawaNoriyuki MiyaueSatoshi TadaRina AndoShinobu MurakamiHitoshi MiyamotoMasahiro NagaiPublished in: Movement disorders clinical practice (2022)
in the PEG-J tube. We observed levodopa metabolism in vitro, but there was no association with levodopa blood concentration. The effect of intestinal bacteria may be limited in patients receiving LCIG therapy.